Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

NCT03661034 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease, Early Onset
Alzheimer Disease
Alzheimer Dementia
Mild Cognitive Impairment
Memory Disorders
Memory Loss
Memory Impairment
Memory Disorders, Age Related
Alzheimer Disease, Late Onset
Cognitive Impairment
Dementia, Mild
Dementia, Alzheimer Type
Cognitive Decline

Interventions

DEVICE: GammaSense Stimulation System (non-invasive, non-significant risk)

Sponsor

Cognito Therapeutics, Inc.